Phase I dose-escalation and dose-expansion trial of CDK4/6 inhibitor FCN-437c in Chinese female patients with ER+HER2-advanced breast cancer (ABC).
文献类型：期刊论文
| 作者 | Zhang, Jian1; Wang, Xiaojia2; Wang, Xian3; Hui, Aimin4; Wu, Zhuli5; Tian, Ling6; Xu, Changjiang7; Yang, Yuchen7; Zhang, Wenjing7; Hu, Xichun1 |
| 刊名 | CANCER RESEARCH
 |
| 出版日期 | 2021-07-01 |
| 卷号 | 81 |
| ISSN号 | 0008-5472 |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| WOS记录号 | WOS:000680263501256 |
| 出版者 | AMER ASSOC CANCER RESEARCH |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/125096]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | 1.Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China 2.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Hangzhou, Peoples R China 3.Sir Run Run Shaw Hosp, Hangzhou, Peoples R China 4.Fosun Pharma USA Inc, Lexington, MA USA 5.Beijing Fosun Pharmaceut Res & Dev Co Ltd, Beijing, Peoples R China 6.Avanc Pharmaceut Co Ltd, Jinzhou, Peoples R China 7.Beijing Fosun Pharmaceut Res & Dev Co Ltd, Shanghai, Peoples R China |
| 推荐引用方式 GB/T 7714 | Zhang, Jian,Wang, Xiaojia,Wang, Xian,et al. Phase I dose-escalation and dose-expansion trial of CDK4/6 inhibitor FCN-437c in Chinese female patients with ER+HER2-advanced breast cancer (ABC).[J]. CANCER RESEARCH,2021,81. |
| APA | Zhang, Jian.,Wang, Xiaojia.,Wang, Xian.,Hui, Aimin.,Wu, Zhuli.,...&Hu, Xichun.(2021).Phase I dose-escalation and dose-expansion trial of CDK4/6 inhibitor FCN-437c in Chinese female patients with ER+HER2-advanced breast cancer (ABC)..CANCER RESEARCH,81. |
| MLA | Zhang, Jian,et al."Phase I dose-escalation and dose-expansion trial of CDK4/6 inhibitor FCN-437c in Chinese female patients with ER+HER2-advanced breast cancer (ABC).".CANCER RESEARCH 81(2021). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。